Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
CARGO Therapeutics, Inc. (CRGX) had Free Cash Flow per Share of $-0.80 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-84.50M |
|
-- |
|
-- |
|
$88.42M |
|
$-88.42M |
|
$3.93M |
|
$-84.50M |
|
$-84.50M |
|
$-84.50M |
|
$-84.50M |
|
$-84.50M |
|
$-84.50M |
|
$-88.42M |
|
$-87.20M |
|
47.85M |
|
47.85M |
|
$-1.77 |
|
$-1.77 |
|
| Balance Sheet Financials | |
$324.81M |
|
$1.11M |
|
$37.15M |
|
$361.96M |
|
$51.55M |
|
-- |
|
$27.95M |
|
$79.50M |
|
$282.46M |
|
$282.46M |
|
$282.46M |
|
46.05M |
|
| Cash Flow Statement Financials | |
$-37.69M |
|
$35.04M |
|
$0.04M |
|
$64.95M |
|
$62.33M |
|
$-2.61M |
|
$6.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-38.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-29.92% |
|
-29.92% |
|
-23.34% |
|
-29.92% |
|
$6.13 |
|
|
Free Cash Flow per Share |
$-0.80 |
$-0.79 |
|